Palonosetron Stada 250 mikrog injektioneste, liuos Финска - Фински - Fimea (Suomen lääkevirasto)

palonosetron stada 250 mikrog injektioneste, liuos

stada arzneimittel ag - palonosetron hydrochloride - injektioneste, liuos - 250 mikrog - palonosetroni

Palonosetron Macure 250 mikrog injektioneste, liuos Финска - Фински - Fimea (Suomen lääkevirasto)

palonosetron macure 250 mikrog injektioneste, liuos

macure pharma aps - palonosetron hydrochloride - injektioneste, liuos - 250 mikrog - palonosetroni

Palonosetron Reig Jofre 250 mikrog injektioneste, liuos Финска - Фински - Fimea (Suomen lääkevirasto)

palonosetron reig jofre 250 mikrog injektioneste, liuos

laboratorio reig jofrÉ s.a. - palonosetron hydrochloride - injektioneste, liuos - 250 mikrog - palonosetroni

MITOMYCIN MEDAC 20 mg jauhe ja liuotin liuosta varten, virtsarakkoon Финска - Фински - Fimea (Suomen lääkevirasto)

mitomycin medac 20 mg jauhe ja liuotin liuosta varten, virtsarakkoon

medac gesellschaft für klinische spezialpräparate mbh - mitomycinum - jauhe ja liuotin liuosta varten, virtsarakkoon - 20 mg - mitomysiini

Imbruvica Европска Унија - Фински - EMA (European Medicines Agency)

imbruvica

janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.

Adrenalin 0.1 mg/ml injektioneste, liuos Финска - Фински - Fimea (Suomen lääkevirasto)

adrenalin 0.1 mg/ml injektioneste, liuos

takeda oy - adrenaline tartrate - injektioneste, liuos - 0.1 mg/ml - adrenaliini

Sinemet 25 mg / 100 mg tabletti Финска - Фински - Fimea (Suomen lääkevirasto)

sinemet 25 mg / 100 mg tabletti

n.v. organon - carbidopa, levodopa - tabletti - 25 mg / 100 mg - levodopa ja dekarboksylaasin estäjä

Bepanthen 50 mg/g emulsiovoide Финска - Фински - Fimea (Suomen lääkevirasto)

bepanthen 50 mg/g emulsiovoide

bayer oy - dexpanthenol - emulsiovoide - 50 mg/g - dekspantenoli

Kardopal 100 mg / 25 mg tabletti Финска - Фински - Fimea (Suomen lääkevirasto)

kardopal 100 mg / 25 mg tabletti

orion corporation - carbidopa, levodopa - tabletti - 100 mg / 25 mg - levodopa ja dekarboksylaasin estäjä

Adrenalin 1 mg/ml injektioneste, liuos Финска - Фински - Fimea (Suomen lääkevirasto)

adrenalin 1 mg/ml injektioneste, liuos

takeda oy - adrenaline - injektioneste, liuos - 1 mg/ml - adrenaliini